Phase 1 Transcranial Magnetic Stimulation Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Intestinal FloraIrritable Bowel SyndromeProbiotic+3 more

The First Affiliated Hospital of Soochow University400 enrolled1 locationNCT06960369

Recruiting

Phase 1Phase 2

Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels

Depression - Major Depressive DisorderTranscranial Magnetic StimulationPlacebo

Universidad de Guanajuato40 enrolled1 locationNCT06667180